ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Allergan
WAREHOUSE
International Warehouse 2
SUBSTANCE
Bimatoprost
,
LUMIGAN® 0.01% is a prescription eye drop medication approved by the FDA, designed to reduce elevated eye pressure in individuals diagnosed with open-angle glaucoma or ocular hypertension.
The primary method for managing high eye pressure, a crucial and manageable risk factor for those with glaucoma, involves using prescription eye drops like LUMIGAN® 0.01% ophthalmic solution. This medication is specifically intended for patients suffering from open-angle glaucoma or those with ocular hypertension.
IndicationLUMIGAN® (bimatoprost ophthalmic solution) 0.01% is indicated for lowering high intraocular pressure (IOP) in individuals with open-angle glaucoma or ocular hypertension.
Dosage and AdministrationThe recommended dosage is one drop in the affected eye(s) once daily in the evening. It is important not to exceed this frequency, as using LUMIGAN® (bimatoprost ophthalmic solution) 0.01% more than once a day can reduce its effectiveness in lowering intraocular pressure. Pressure reduction typically begins around 4 hours after the first dose, with maximum effect occurring between approximately 8 to 12 hours later.